Skip to main content
. 2018 Jun 6;132(6):598–607. doi: 10.1182/blood-2018-01-821629

Figure 2.

Figure 2.

Kaplan-Meier plots. (A) Duration of CRc and (B) OS (ITT analysis set). *30-mg starting dose with permitted escalation to 60 mg for lack of or loss of initial response. 60-mg starting dose with permitted escalation to 90 mg for lack of or loss of initial response. QD, once daily.